STAT3 and neoplasm: On the other hand, it shows anti-tumor activity through the activation of lymphocytes including cytotoxic T (CD8+) and natural killer (NK) cells, and inactivation of the nuclear factor-κB (NF-κB) and STAT3 signaling pathways [15].